Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Head and Neck Cancer

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 41 articles: HTML format

Single Articles

June 2009
1. NIU G , Li Z, Xie J, Le QT, et al
   PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. MENDA Y , Boles Ponto LL, Dornfeld KJ, Tewson TJ, et al
   Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. DIRIX P , Vandecaveye V, De Keyzer F, Stroobants S, et al
   Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   April 2009
4. SCHODER H , Fury M, Lee N, Kraus D, et al
   PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. KRAUSE BJ , Herrmann K, Wieder H, Zum Buschenfelde CM, et al
   18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. ETEROVIC D , Markovic V, Punda A, Antunovic Z, et al
   131I Radiation Dose Distribution in Metastases of Thyroid Carcinoma.
   J Nucl Med. 2009.
   PubMed     Related articles   
   
   
   
7. CHAMPION C , Zanotti-Fregonara P, Hindie E
   131I Radiation Dose Distribution in Metastases of Thyroid Carcinoma.
   J Nucl Med. 2009.
   PubMed     Related articles   
   
   
   March 2009
8. MARTINEZ-MOLLER A , Souvatzoglou M, Delso G, Bundschuh RA, et al
   Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   February 2009
9. NOTHELFER EM , Zitzmann-Kolbe S, Garcia-Boy R, Kramer S, et al
   Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer.
   J Nucl Med. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. TROOST EG , Bussink J, Oyen WJ, Kaanders JH, et al
    18F-FDG and 18F-FLT Do Not Discriminate Between Reactive and Metastatic Lymph Nodes in Oral Cancer.
    J Nucl Med. 2009.
    PubMed     Related articles   
    
    
    
11. SIOKA C , Fotopoulos A
    Pregnancy outcome after 131I therapy.
    J Nucl Med. 2009;50:327.
    PubMed     Related articles   
    
    
    
12. BOURGEOIS P
    A proposition for the use of radioiodine in WDTC management.
    J Nucl Med. 2009;50:328-9.
    PubMed     Related articles   
    
    
    January 2009
13. SPANU A , Solinas ME, Chessa F, Sanna D, et al
    131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging.
    J Nucl Med. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
14. ABGRAL R , Querellou S, Potard G, Le Roux PY, et al
    Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
15. SCHMIDT D , Szikszai A, Linke R, Bautz W, et al
    Impact of 131I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
16. SHIGA T , Morimoto Y, Kubo N, Katoh N, et al
    A New PET Scanner with Semiconductor Detectors Enables Better Identification of Intratumoral Inhomogeneity.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
17. JUNG KH , Paik JY, Ko BH, Lee KH, et al
    Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
    J Nucl Med. 2008;49:1966-72.
    PubMed     Related articles    Abstract available
    
    
    November 2008
18. KOMAR G , Seppanen M, Eskola O, Lindholm P, et al
    18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
19. CHEN L , Luo Q, Shen Y, Yu Y, et al
    Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
20. JUDSON BL , Shaha AR
    Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism.
    J Nucl Med. 2008;49:1813-8.
    PubMed     Related articles    Abstract available
    
    
    
21. SUH C , Kang YK, Roh JL, Kim MR, et al
    Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck.
    J Nucl Med. 2008;49:1783-9.
    PubMed     Related articles    Abstract available
    
    
    October 2008
22. ZANOTTI-FREGONARA P , Rubello D, Hindie E
    Bone Metastases of Differentiated Thyroid Cancer: The Importance of Early Diagnosis and 131I Therapy on Prognosis.
    J Nucl Med. 2008.
    PubMed     Related articles   
    
    
    September 2008
23. KIM HJ , Kim YH, Lee DS, Chung JK, et al
    In Vivo Imaging of Functional Targeting of miR-221 in Papillary Thyroid Carcinoma.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
24. SCOTT AM , Gunawardana DH, Bartholomeusz D, Ramshaw JE, et al
    PET Changes Management and Improves Prognostic Stratification in Patients with Head and Neck Cancer: Results of a Multicenter Prospective Study.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
25. BAO A , Goins B, Dodd GD 3rd, Soundararajan A, et al
    Real-Time Iterative Monitoring of Radiofrequency Ablation Tumor Therapy with 15O-Water PET Imaging.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
26. BAEK CH , Chung MK, Son YI, Choi JY, et al
    Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
27. REMY H , Borget I, Leboulleux S, Guilabert N, et al
    131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients.
    J Nucl Med. 2008.
    PubMed     Related articles    Abstract available
    
    
    
28. KOOPMANS KP , Jager PL, Kema IP, Kerstens MN, et al
    111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
    J Nucl Med. 2008;49:1232-7.
    PubMed     Related articles    Abstract available
    
    
    July 2008
29. HAY ID , McDougall IR, Sisson JC
    Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. NAKAGAWA T , Yamada M, Suzuki Y
    18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles.
    J Nucl Med. 2008;49:1053-9.
    PubMed     Related articles    Abstract available
    
    
    June 2008
31. NAHMIAS C , Lemmens C, Faul D, Carlson E, et al
    Does Reducing CT Artifacts from Dental Implants Influence the PET Interpretation in PET/CT Studies of Oral Cancer and Head and Neck Cancer?
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
32. JENTZEN W , Freudenberg L, Eising EG, Sonnenschein W, et al
    Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
33. GARSI JP , Schlumberger M, Rubino C, Ricard M, et al
    Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. TUTTLE RM , Brokhin M, Omry G, Martorella AJ, et al
    Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. SILBERSTEIN EB
    Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine.
    J Nucl Med. 2008;49:546-9.
    PubMed     Related articles    Abstract available
    
    
    March 2008
36. ONG SC , Schoder H, Lee NY, Patel SG, et al
    Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. JAGER PL , Chirakal R, Marriott CJ, Brouwers AH, et al
    6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
38. MULLER C , Forrer F, Schibli R, Krenning EP, et al
    SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. BURNISTON MT , Wilson DJ
    Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
    J Nucl Med. 2008;49:166.
    PubMed     Related articles   
    
    
    September 2007
40. WALTER MA , Turtschi CP, Schindler C, Minnig P, et al
    The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. AIDE N , Bardet S
    Would Patient Selection Based on Both Calcitonin Blood Level and Doubling Time Improve 18F-FDG PET Sensitivity in Restaging of Medullary Thyroid Cancer?
    J Nucl Med. 2007;48:1574.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: